{"schema_version":"secwatch.filing_event.v1","accession":"0001062993-25-010687","form_type":"8-K","ticker":"MDCX","cik":"0001997296","company_name":"Medicus Pharma Ltd.","filed_at":"2025-06-02T23:59:59+00:00","discovered_at":"2026-05-14T18:02:50.658107+00:00","generated_at":"2026-05-20T03:22:51.909590+00:00","sec_items":["1.01","3.02","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Medicus Pharma prices $7M public offering of 2.26M units at $3.10/unit; closes June 2","bullets":["Gross proceeds $7,006,000 from 2,260,000 units at $3.10/unit; each unit = 1 common share + 1 warrant.","Warrants exercisable at $3.10/share, expire 5 years from issuance; not listed on exchange.","Net proceeds to fund Phase 2 proof-of-concept trial for basal cell carcinoma using doxorubicin tip loaded dissolvable microarray needle skinpatch.","Co. also issued $1.25M second-tranche debenture to Yorkville on June 2, 2025, bringing total Yorkville debentures to $2.5M.","Placement agents Maxim, Brookline, D. Boral; cash fee 7.5% of gross proceeds."],"urls":{"canonical":"https://secwatch.observer/filing/0001062993-25-010687","json":"https://secwatch.observer/filing/0001062993-25-010687.json","markdown":"https://secwatch.observer/filing/0001062993-25-010687.md","text":"https://secwatch.observer/filing/0001062993-25-010687.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1997296/000106299325010687/0001062993-25-010687-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1997296/000106299325010687/form8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-20T03:22:51.909590+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}